{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:10:27Z","timestamp":1754557827887},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.1001\/jamaophthalmol.2020.1279","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T15:02:27Z","timestamp":1588863747000},"page":"732","source":"Crossref","is-referenced-by-count":17,"title":["Macular Abnormalities Associated With 5\u03b1-Reductase Inhibitor"],"prefix":"10.1001","volume":"138","author":[{"given":"Yong Kyun","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Woong","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"eoi200034r1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/archopht.126.4.519","article-title":"Menopausal and reproductive factors and risk of age-related macular degeneration.","volume":"126","author":"Feskanich","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"eoi200034r2","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/IAE.0000000000000198","article-title":"Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.","volume":"34","author":"Nudleman","year":"2014","journal-title":"Retina"},{"issue":"11","key":"eoi200034r3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/02713683.2017.1337155","article-title":"Gender differences in the relationship between sex hormone deficiency and soft drusen.","volume":"42","author":"Kwon","year":"2017","journal-title":"Curr Eye Res"},{"key":"eoi200034r4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2018.00066","article-title":"Gonadal hormones and retinal disorders: a review.","volume":"9","author":"Nuzzi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"pt 2","key":"eoi200034r5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/eye.1998.60","article-title":"Systemic risk factors for idiopathic macular holes: a case-control study.","volume":"12","author":"Evans","year":"1998","journal-title":"Eye (Lond)"},{"issue":"5","key":"eoi200034r6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/IAE.0000000000000082","article-title":"First symptoms and their age of onset in macular telangiectasia type 2.","volume":"34","author":"Heeren","year":"2014","journal-title":"Retina"},{"issue":"3","key":"eoi200034r7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9394(00)00781-9","article-title":"Tamoxifen retinopathy in a male patient.","volume":"131","author":"Yanyali","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi200034r8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ajo.2014.02.046","article-title":"Pseudocystic foveal cavitation in tamoxifen retinopathy.","volume":"157","author":"Doshi","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi200034r9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0002-9394(99)80190-1","article-title":"Long-term tamoxifen citrate use and potential ocular toxicity","volume":"125","author":"Gorin","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"eoi200034r10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","article-title":"Perifoveal m\u00fcller cell depletion in a case of macular telangiectasia type 2.","volume":"117","author":"Powner","year":"2010","journal-title":"Ophthalmology"},{"key":"eoi200034r11","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/IAE.0000000000001789","article-title":"Sex steroids and macular telangiectasia type 2.","volume":"38","author":"M\u00fcller","year":"2018","journal-title":"Retina"},{"issue":"10","key":"eoi200034r12","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1093\/annonc\/mdx402","article-title":"Risk of age-related macular degeneration in patients with prostate cancer: a nationwide, population-based cohort study.","volume":"28","author":"Lin","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"eoi200034r13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5021\/ad.2013.25.2.181","article-title":"The annual changes of clinical manifestation of androgenetic alopecia clinic in Korean males and females: a outpatient-based study.","volume":"25","author":"Jang","year":"2013","journal-title":"Ann Dermatol"},{"issue":"3","key":"eoi200034r14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.21032\/jhis.2018.43.3.217","article-title":"The benign prostatic hyperplasia incidence rate in Korea: using National Health Insurance Service data.","volume":"43","author":"Go","year":"2018","journal-title":"J Health Info Stat"},{"issue":"3","key":"eoi200034r15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/pcan.2011.12","article-title":"National-wide data on the treatment of BPH in Korea.","volume":"14","author":"Kang","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"20","key":"eoi200034r16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"eoi200034r17","article-title":"Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.","volume":"46","author":"Lee","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"eoi200034r18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1527-3458.2006.00053.x","article-title":"A new look at the 5alpha-reductase inhibitor finasteride.","volume":"12","author":"Finn","year":"2006","journal-title":"CNS Drug Rev"},{"issue":"1","key":"eoi200034r19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis.","volume":"77","author":"Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"eoi200034r20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2016.09.032","article-title":"Comparative effectiveness of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review and meta-analysis.","volume":"71","author":"Dahm","year":"2017","journal-title":"Eur Urol"},{"issue":"4","key":"eoi200034r21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ucl.2019.07.001","article-title":"Hormone therapy for transgender adults.","volume":"46","author":"Radix","year":"2019","journal-title":"Urol Clin North Am"},{"issue":"3","key":"eoi200034r22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11154-015-9319-y","article-title":"Adverse effects of 5a-reductase inhibitors: what do we know, don\u2019t know, and need to know?","volume":"16","author":"Traish","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"eoi200034r23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5a-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.","volume":"8","author":"Traish","year":"2011","journal-title":"J Sex Med"},{"issue":"5","key":"eoi200034r24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5a-reductase inhibitor.","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"35","key":"eoi200034r25","doi-asserted-by":"crossref","first-page":"25801","DOI":"10.1074\/jbc.M703268200","article-title":"Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.","volume":"282","author":"Askew","year":"2007","journal-title":"J Biol Chem"},{"issue":"3","key":"eoi200034r26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/andr.12186","article-title":"Endocrine control of benign prostatic hyperplasia.","volume":"4","author":"La Vignera","year":"2016","journal-title":"Andrology"},{"issue":"4","key":"eoi200034r27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2826.2009.01840.x","article-title":"A role for the androgen metabolite, 5a-androstane-3\u00df,17\u00df-diol, in modulating oestrogen receptor \u00df-mediated regulation of hormonal stress reactivity.","volume":"21","author":"Handa","year":"2009","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"eoi200034r28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice.","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"key":"eoi200034r29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ERa) and beta (ER\u00df): subtype-selective ligands and clinical potential.","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"issue":"7","key":"eoi200034r30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjo.85.7.877","article-title":"Presence of oestrogen receptor type beta in human retina.","volume":"85","author":"Munaut","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"eoi200034r31","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1073\/pnas.96.12.7077","article-title":"Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta.","volume":"96","author":"M\u00e4kel\u00e4","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"eoi200034r32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neuroscience.2010.08.019","article-title":"Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity.","volume":"170","author":"Bryant","year":"2010","journal-title":"Neuroscience"},{"issue":"8","key":"eoi200034r33","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1615233114","article-title":"Estrogen receptor a wields treatment-specific enhancers between morphologically similar endometrial tumors","volume":"114","author":"Droog","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"eoi200034r34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/ERC-13-0444","article-title":"Support of a bi-faceted role of estrogen receptor \u00df (ER\u00df) in ERa-positive breast cancer cells.","volume":"21","author":"Jonsson","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"eoi200034r35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0773.2002.910305.x","article-title":"Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells.","volume":"91","author":"M\u00e4enp\u00e4\u00e4","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"eoi200034r36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2.","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"pt 6","key":"eoi200034r37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/eye.1999.217","article-title":"Ocular toxicity in low-dose tamoxifen: a prospective study.","volume":"13","author":"Noureddin","year":"1999","journal-title":"Eye (Lond)"},{"issue":"9","key":"eoi200034r38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy.","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov Disord"},{"key":"eoi200034r39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2017.05.064","article-title":"The risk of dementia with the use of 5 alpha reductase inhibitors.","volume":"379","author":"Welk","year":"2017","journal-title":"J Neurol Sci"},{"issue":"6","key":"eoi200034r40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0002-9394(14)70321-6","article-title":"Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.","volume":"117","author":"Heier","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi200034r41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(81)35071-4","article-title":"Tamoxifen retinopathy: a clinicopathologic report.","volume":"88","author":"Kaiser-Kupfer","year":"1981","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200034r42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1677\/jme.1.01725","article-title":"Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.","volume":"34","author":"Makridakis","year":"2005","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"eoi200034r43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028840","article-title":"Androgen regulation of 5a-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2765649\/jamaophthalmology_shin_2020_oi_200034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T07:42:23Z","timestamp":1615621343000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2765649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.1279","relation":{},"ISSN":["2168-6165"],"issn-type":[{"type":"print","value":"2168-6165"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}